alexa Abstract | Molecular Chaperones and Co-chaperones as Therapeutic Targets for Cancer
ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial Open Access


Cancer is a devastating disease that has affected millions of people, consumed tremendous efforts in the treatment/care and is incurable. Statistics from show 14,140,254 people were living with cancer in 2013 in US with 1,685,210 new cases projected and 595,690 estimated deaths to occur due to cancer in 2016. Number of people surviving cancer (measured as 5-year survival rate) has increased by 18% (48.7% in 1975 to 66.9% in 2012) during the last half century. This number appears to be small if we consider the contribution of proactive care for example, early detections, and attention to life style and aggressive chemical/radiation therapy and at the same time stare at a bleak hope of any apparent breakthrough in next 10 years.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Atta Ahmad, Mahvish Muzaffar


Molecular Pharmacy,Molecular and Cellular Biology

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version